KRYS

-4.1%🟢 Fundamentally supported

Krystal Biotech, Inc. Common Stock · Healthcare

$316.58Vol 226.2K · 0.7× normalMkt cap −$0.40BMarket closed — 2026-10-16 session

What happened

Move

-4.1%

Price

$316.58

Volume

226.2K

0.7× normal

Market cap

$9.37B

−$0.40B today

Why it moved

Legal / regulatorymedium confidence

Krystal Biotech Reports KB113 Lesion Regression in Gorlin Syndrome Pilot Study as FDA Discussions Begin — finnhub-news
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $361 Price Target — finnhub-news

Possible catalyst: legal / regulatory, 2.9pp below its sector.

Verdict — was the move justified?

🟢 Fundamentally supported

Legal / regulatory — direction and rough magnitude are consistent with the identified fundamental catalyst.

How unusual is this move

σ score

1.9σ

vs own 20d volatility

Percentile

85th

of 1270 daily moves

Avg daily move

±2.4%

own 5y average

vs sector

-2.9%

beyond sector median

What happened after similar moves

144 similar down moves in KRYS’s 5-year history:

After 5 days

+1.1%

59% higher

After 20 days

+3.4%

62% higher

Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.

Fundamental context

V 25G 0P 95H 75Q 52

Insider activity (90d): net selling $932.5K

Valuation context

P/E (TTM)

38.8

5y median 43.1

P/E percentile

30%

vs own 3y history

FCF yield

0.0%

Valuation sits near the middle of its own historical range (30th percentile).

Full fundamental analysis on PreMarketPrice

Pillar scores, financial statements, valuation history, news & more for KRYS

→